|Fastest Growing Market:||Asia Pacific|
|Largest Market:||North America|
Need a report that reflects how COVID-19 has impacted this market and its growth?
The oncology nutrition market is expected to register a CAGR of 8.9% over the forecast period.
COVID-19 had a big impact on the market for oncology nutrition. For instance, per the article published in 2022 under the title “Nutrition in Cancer Patients Positive for COVID-19; Case Series and a Systematic Review of Literature”, the study focused on creating recommendations on the nutritional protocol for the management & prevention of complications during ongoing COVID-19 pandemic for all cancer patients. Patients who have cancer are more susceptible to illnesses due to either direct immune system impairment or anticancer medication. Furthermore, as per the article titled “Nutrition and Micronutrients in Cancer Patients Positive for COVID-19” published in 2021, the study showed the importance of diet in the predisposition, prevention, and management of COVID-19 in cancer patients, as well as the role of dietary supplementation with vitamins or minerals, and microbiota in the COVID-19 period. The same source points out the need to develop nutritional maintenance and complication control guidelines for all patients with cancer during the continuing COVID-19 pandemic. Hence due to the aforesaid factors, COVID-19 had a significant impact on the market studied.
The major factors attributing to the growth of the oncology nutrition market are the rising prevalence of cancer cases worldwide. For instance, as per the report from Globocan 2020, the incidence of cancer cases in 2020 was 19.3 million globally. The number is expected to rise to 28.9 million by 2040. The use of nutritional products during and after the treatment of cancer gives the ability to fight disease and offers strength and stamina against the treatment's after-effects which is driving the market growth. And there are a few more factors that are playing crucial roles in taking the oncology nutrition market to the next level, among them increasing demand for nutrition products for oncology in homecare settings and increasing demand for enteral nutrition products are expected to further propel the growth of the oncology nutrition market.
Furthermore, the awareness provided by the government and private agencies is one of the main fuelling factors for market growth. For instance, as per the 2022 update from the American Society of Clinical Oncology (ASCO) Cancer.Net, after cancer treatment is complete, most experts recommend a healthy diet that includes plenty of fruits, vegetables, and whole grains. Moreover, the presence of competitors, new product introductions, and collaborations relating to the market studied, boost the growth of the market. For instance as per the report from 2020, Esperer launched its nutrition development center in Hyderabad, the facility in Hyderabad is anticipated to house a variety of cohesive capabilities including investigative workrooms and product improvement sub-centers with a devoted laboratory for analyzing sensory components, packing, and taste. At the new EsNDC, Esperer is focused and keeps a track of cancer patients to identify dietary changes and assist in creating novel nutrition products and delivery technologies to broaden its existing and future product offerings.
Hence as per the aforementioned factors, the oncology nutrition market is likely to grow over the forecast period. However, the high cost of premium nutrition products for oncology restrains the market growth.
Scope of the Report
As per the scope of the report, oncology nutrition is a vital part of the entire process of recovering from cancer. Consuming a wide variety of foods and nutritious meals helps in coping with the heavy medication that is a part of cancer treatment. Following well-balanced oncology, nutrition helps in improving strength, maintaining body weight, and assisting the body in recovering from cancer. The Oncology Nutrition Market is segmented by Cancer Type (Head & Neck Cancer, Stomach & Gastrointestinal Cancers, Blood Cancer, Breast Cancer, Lung Cancer, Other cancers), End-User (Hospitals, Home Care and Others), and Geography (North America, Europe, Asia-Pacific, South America, Middle East, and Africa). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.
|By Cancer Type|
|Head & Neck Cancer|
|Stomach & Gastrointestinal Cancers|
|By End User|
Key Market Trends
Lung Cancer is Expected to Witness a Healthy Growth Over the Forecast Period
The lung cancer segment is likely to grow during the study period owing to the factors such as the high prevalence of the lung cancer population worldwide, an increase in lung cancer nutritional supplements, and rising awareness and importance of taking nutritional supplements. For instance, as per the report from International Agency for Research on Cancer, the number of people affected by lung cancer was 2.21 million in 2020 and the number is expected to rise to 3.50 million by 2040. As the number of people with cancer increases, the demand for oncology nutrition is likely to upsurge, as nourishment gives the ability to fight disease and offers strength and stamina against the treatment's after-effects.
Furthermore, government initiatives are urging people to have to take proper nutrition while in the cancer treatment and post-treatment. For that purpose, the agencies are relaxing and preparing so many regulations relating to the same. For instance, in May 2021, U.S. Senators Susan Collins (R-ME) and Gary Peters (D-MI) introduced the “Medical Nutrition Therapy Act”, bipartisan legislation that would expand Medicare Part B to cover medical nutrition therapy (MNT) services for additional conditions, including cancer, prediabetes, eating disorders, malnutrition, gastrointestinal diseases (e.g., celiac disease), cardiovascular disease, HIV/AIDS, and other diseases or conditions that cause unintentional weight loss. Such movements are likely to help people financially and motivate them to be keener on taking nutritional supplements thereby boosting the market growth.
Hence as per the factors mentioned above, the lung cancer segment is likely to grow in the oncology nutrition market over the forecast period.
To understand key trends, Download Sample Report
North America Dominates the Market and Expected to do Same in the Forecast Period
North America is expected to dominate the overall oncology nutrition market, throughout the forecast period. This is owing to factors such as the rising prevalence of cancer and the availability of advanced healthcare infrastructure among the major factors. For instance, as per the report from the American Cancer Society, the estimated number of new cancer cases is likely to be 1.9 million in the United States. Moreover, government initiatives, product launches, and collaborations in cancer nutrition supplements boost market growth. For instance, the Academy of Nutrition and Dietetics conducted the “2022 Oncology Nutrition Symposium” on June 2022. In the symposium, they discuss the practice of oncology nutrition that covers research, prevention, treatment, recovery, palliative care, and hospice.
Furthermore, the number of cancer cases in Canada was reported as 274,364 in 2020 and the estimated incidence of cancer cases is 373,983 by 2035. The increasing incidence of cancer cases in the region of North America is anticipated to boost market growth. Additionally, a lot of certification programs and awareness classes are conducted regionally to provide education to cancer patients and providers regarding the importance of oncology nutrition. For example, the Oncology Nutrition Institute (ONI) provides evidence-based educational certification and training programs in the field of modern, metabolic, innovative, integrative, and outcomes-based oncology nutrition therapy. Its flagship 250-Hour Oncology Nutrition Consulting (ONC) certification program is an intensive training program designed for qualified nutrition, health, and medical practitioners. Its flagship 250-Hour Oncology Nutrition Consulting (ONC) certification program is an intensive training program designed for qualified nutrition, health, and medical practitioners.
Hence as per the factors mentioned above, North America is expected to witness growth over the forecast period.
To understand geography trends, Download Sample Report
The oncology nutrition market is consolidated and consists of a few major players. In terms of market share, few of the major players are currently dominating the market. And some prominent players are vigorously making acquisitions and joint ventures with the other companies and launching new products to consolidate their market positions across the globe. Some of the companies which are currently dominating the market are Abbott Laboratories, Nestle S.A., Fresenius Kabi AG, B.Braun Melsungen AG, and Hormel Foods Corporation.
- In July 2022, Nestle launched China’s first Foods for Special Medical Purpose (FSMP) for patients suffering from tumor-related conditions, after going through a five-year-long approval process from the Chinese regulator.
- In December 2021, Nestlé Health Science launched a new platform to provide information and support to individuals and their caregivers regarding the importance of nutrition for cancer patients. "MyCancerMyNutrition.com" was developed with healthcare providers to offer information and support at every phase of the disease, from diagnosis, beginning treatment, and ending treatment. Areas covered include coping with side effects, food & nutrition, wellbeing, and routine.
Table of Contents
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising prevalence of Cancer Worldwide
4.2.2 Introduction of New Oncology Nutrition Products
4.3 Market Restraints
4.3.1 High Cost of Premium Nutrition Products for Oncology
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Cancer Type
5.1.1 Head & Neck Cancer
5.1.2 Stomach & Gastrointestinal Cancers
5.1.3 Blood Cancer
5.1.4 Breast Cancer
5.1.5 Lung Cancer
5.1.6 Other cancers
5.2 By End User
5.2.2 Home Care
5.3.1 North America
188.8.131.52 United States
184.108.40.206 United Kingdom
220.127.116.11 Rest of Europe
18.104.22.168 South Korea
22.214.171.124 Rest of Asia-Pacific
5.3.4 Middle East and Africa
126.96.36.199 South Africa
188.8.131.52 Rest of Middle East and Africa
5.3.5 South America
184.108.40.206 Rest of South America
6. COMPETITIVE LANDSCAPE
*List Not Exhaustive
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.3 Fresenius Kabi AG
6.1.4 B.Braun Melsungen AG
6.1.5 Hormel Foods Corporation
6.1.6 Sofina (Danone S.A.)
6.1.7 Meiji Holdings Company, Ltd.
6.1.8 Global Health Products, Inc.
6.1.9 Victus, Inc.
6.1.10 Reckitt Benckiser Group plc (Mead Johnson & Company, LLC)
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
You can also purchase parts of this report. Do you want to check out a section wise price list?
Frequently Asked Questions
What is the study period of this market?
The Global Oncology Nutrition Market market is studied from 2019 - 2027.
What is the growth rate of Global Oncology Nutrition Market?
The Global Oncology Nutrition Market is growing at a CAGR of 8.9% over the next 5 years.
Which region has highest growth rate in Global Oncology Nutrition Market?
Asia Pacific is growing at the highest CAGR over 2021- 2026.
Which region has largest share in Global Oncology Nutrition Market?
North America holds highest share in 2021.
Who are the key players in Global Oncology Nutrition Market?
Abbott Laboratories, Fresenius Kabi AG, B.Braun Melsungen AG, Hormel Foods Corporation (Hormel Health Labs), Nestlé are the major companies operating in Global Oncology Nutrition Market.